Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The reconstruction of the dose distribution in compass 3.1 for monaco-dmlc and eclipse imrt plans with jaw tracking enabled result in the same dose distribution as the dose computation which has the potential of being erroneous. the reason for the wrong result is an error in the software that causes the reconstruction to be based only on the calculated fluence and not on the fluence derived from the measurement.